IL25 and breast carcinoma: The results revealed that both cytokines activated similar oncogenic pathways in breast malignant cell lines leading to Docetaxel resistance and generation of LMW cyclin E. In contrast to previous report, we failed to found IL-17E expression by non-transformed epithelial cells and to reproduce its potential induction of breast cancer cell apoptosis.